Mizuho Une
Kure, 7370112, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
FLG249 Exhibits FXR Antagonist Activity by Inducing Dissociation of Both Corepressors and Coactivators from FXR.
Journal: Biological & pharmaceutical bulletin
Published: July 16, 2025
Fecal fatty acid-linked bile acid profiles in pediatric patients with ulcerative colitis.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: October 08, 2024
FXR Antagonist FLG249 Lowers Hepatic Triacylglycerol and Serum Cholesterol Level in High-Fat Diet-Induced Obese Mice.
Journal: Biological & pharmaceutical bulletin
Published: August 13, 2024
Discovery of FXR/PPARγ dual partial agonist.
Journal: Bioorganic & medicinal chemistry
Published: February 03, 2023
Hyodeoxycholic Acid (HDCA) Prevents Development of Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice: Possible Role of Synergism between DSS and HDCA in Increasing Fecal Bile Acid Levels.
Journal: Biological & pharmaceutical bulletin
Published: October 02, 2022
Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum.
Journal: ACS medicinal chemistry letters
Published: December 06, 2020
Dual Agonist of Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo.
Journal: Hepatology (Baltimore, Md.)
Published: June 12, 2020
N1-Substituted benzimidazole scaffold for farnesoid X receptor (FXR) agonists accompanying prominent selectivity against vitamin D receptor (VDR).
Journal: Bioorganic & medicinal chemistry
Published: March 26, 2020
Identification of potent farnesoid X receptor (FXR) antagonist showing favorable PK profile and distribution toward target tissues: Comprehensive understanding of structure-activity relationship of FXR antagonists.
Journal: Bioorganic & medicinal chemistry
Published: March 05, 2019
Late-onset Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.
Journal: Internal medicine (Tokyo, Japan)
Published: February 13, 2018
Nonacidic Chemotype Possessing N-Acylated Piperidine Moiety as Potent Farnesoid X Receptor (FXR) Antagonists.
Journal: ACS medicinal chemistry letters
Published: September 03, 2017
Last Updated: 09/26/2026